• Rimma Gamirova
  • Marina Farnosova
  • Regina Gamirova



Abstract. The study analyzes the effectiveness of short-term and long-term treatment of West syndrome with the help of different antiepileptic drugs (AEDs) (combined therapy with the inclusion of Tetracosactide in comparison with nonhormonal antiepileptic drugs). The RR risk ratio was calculated using Review Manager 5.2 ( A complete absence of seizures was considered as a favorable outcome. 150 children with confirmed West syndrome who received treatment at A.Yu.Ratner Pediatic Clinical Hospital №8 (Kazan, Russian Federation) were included into a retrospective observational study. 90 children treated with Tetracosactide in combination with AEDs were included into Group I. Group II consisted of 60 children who received any AEDs except Tetracosactide. The results showed that the effectiveness of Tetracosactide with complete absence of seizures as favorable outcome with short-term observation (at least 6 months) is higher than after treatment with other antiepileptic drugs in the absence of difference in safety. Long-term results of treatment (complete clinical remission during three
years or more) did not have a significant difference.
Keywords: West syndrome, Tetracosactide, antiepileptic drugs, epilepsy, effectiveness of treatment.


Wilmshurst J.M., Gaillard W.D., Vinayan K.P. et al. Summary of recommendations for the management of infantile

seizures: Task Force Report for the ILAE Commission of Pediatrics, Epilepsia, vol. 56, issue 8, e1185-97, 2015.

Hancock E.C., Osborne J.P., Edwards S.W. Treatment of infantile spasms, Cochrane Database of Systematic

Reviews, vol. 5, issue 6, CD001770, 2013.

Sorel L., Dusaucy-Bayloye H. A propos de 21 cas d‘hypsarythmie de Gibbs. Son Traitement spectaculaire par

l’ACTH, Acta Neurol Psychiatr Belg, vol. 58, issue 2, pp. 130-141, 1958.

Cilio M.R., Kartashov A.I., Vigevano F. The long-term use of felbamate in children with severe refractory epilepsy,

Epilepsy Res, vol. 47, pp. 1–7, 2001.

Lawlor K.M., Devlin A.M. Levetiracetam in the treatment of infantile spasms, Eur J Paediatr Neurol., vol. 9: e19–

e22, 2005.

Mikati M.A., Fayad M., Koleilat M. et al. Efficacy, tolerability, and kinetics of lamotrigine in infants, J Pediatr, vol.

, pp. 31–35, 2002.

Peltzer B., Alonso W.D., Porter B.E. Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for

infantile spasms, J Child Neurol, vol, 24, issue 4, pp. 400-405, 2009.

Weber A., Cole J.W., Mytinger J.R. Infantile spasms respond poorly to Topiramate, Pediatr Neurol, vol. 53, issue 2,

pp. 130-134.

Askalan R., Mackay M., Brian J. Prospective preliminary analysis of the development of autism and epilepsy in

children with infantile spasms, J Child Neurol, vol. 18, issue 3, pp. 165-170, 2003.

Wild J.M., Chiron C., Ahn H. et al. Visual field loss in patients with refractory partial epilepsy treated with

vigabatrin: final results from an open-label, observational, multicentre study, CNS Drugs, vol. 23, issue 11, pp. 965-

, 2009.

Pellock J.M., Hrachovy R., Shinnar S. Infantile spasms: a U.S. consensus report. Epilepsia, vol. 51, issue 10, pp.

-2189, 2010.

Wheless J.W., Gibson P.A., Rosbeck K.L. Infantile spasms (West syndrome): update and resources for pediatricians

and providers to share with parents. BMC Pediatr. vol. 12, p. 108, 2012.

Hrachovy R.A., Frost J.D. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West

syndrome), J Clin Neurophysiol, vol. 20, issue 6, pp. 408-425, 2003.

Mackay M.T., Weiss S.K., Adams-Webber T. et al. Practice parameter: medical treatment of infantile spasms:

report of the Аmerican Academy of Neurology and the Child Neurology Society, Neurology, vol. 62, issue 10, pp.

–1681, 2004.

Rajaraman R.R., Lay J., Alayari A. et al. Prevention of infantile spasms relapse: Zonisamide and topiramate provide

no benefit, Epilepsia, vol. 57, issue 8, pp. 1280-1287.

O'Callaghan F.J., Edwards S.W., Alber F.D. et al. Safety and effectiveness of hormonal treatment versus hormonal

treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial, Lancet Neurol,

vol. 16, pp. 33-42, 2017.

Ziganshina L.E., Gamirova R.G, Abakumova T.R. Gabapentin monotherapy for epilepsy, Cochrane Database of

Systematic Reviews, vol. 6: CD012710, 2017.

Gamirova R., Akhutina T., Gorobets E., Shaykhutdinova R. The effect of antiepileptic therapy on the development

of cognitive functions in children with epilepsy: introduction to the problem, Helix, vol. 8, issue 1, pp. 2941-2944,

Esin R.G., Gorobets E.A., Esin O.R. Speech disorders in patients with vascular encephalopathy, European Journal

of Clinical Investigation, t. 47, pp. 56-57, 2017.

Gorobets, E.A., Kulsharipova, R.E., Lotfullina, N.Z. Semantico-phonological disorders in patients with Wernicke's

aphasia, Social Sciences (Pakistan), vol. 10, issue 5, pp. 566-570, 2015.

Riikonen R. Recent Advances in the Pharmacotherapy of Infantile Spasms, CNS Drugs, vol. 28, pp. 279–290,